Cezocon-S 500mg/500mg Injection
Marketer
Iscon Life Sciences
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Cezocon-S 500mg/500mg Injection
Combiflox 500mg/500mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under medical guidance. Complete the prescribed regimen; premature cessation may compromise effectiveness. Regularly scheduled doses are crucial. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Report any worsening symptoms or allergic reactions (rash, pruritus, edema, dyspnea) immediately. Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Monitoring may include laboratory tests to assess treatment efficacy.
Primary Ingredients of Cezocon-S 500mg/500mg Injection
No text provided to rephrase.
Uses of Cezocon-S 500mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Cezocon-S 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cezocon-S 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cezocon-S 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cezocon-S 500mg/500mg Injection works:
Cefoperazone and Sulbactam 500mg/500mg (Cezocon-S Injection) is a dual-action antibiotic formulation. Cefoperazone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Cefoperazone's antibacterial efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Cezocon-S 500mg/500mg Injection treatment can trigger adverse effects including facial redness, tachycardia, queasiness, increased thirst, chest discomfort, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable formulation Cezocon-S 500mg/500mg is generally deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Cezocon-S 500mg/500mg Injection is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Cezocon-S 500mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cezocon-S 500mg/500mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cezocon-S 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cezocon-S 500mg/500mg Injection :
Omit a Cezocon-S 500mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Cezocon-S 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently